Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Carisma Therapeutics
Special Reports
The 2025 Biotech Graveyard
Biotechs, beware: You're in for a scare.
Darren Incorvaia
Oct 31, 2025 5:00am
Carisma's lifeline disappears as reverse merger plans break down
Sep 18, 2025 10:40am
Carisma winds down operations, lays off 95% of remaining staff
Apr 1, 2025 7:20am
AI firm Xaira powers up C-suite with pharma vet—Chutes & Ladders
Dec 13, 2024 8:30am
Carisma axes sole clinical candidate, lays off 34% of staff
Dec 9, 2024 10:58am
Carisma's Moderna-powered cell therapy shrinks tumors in mice
Nov 8, 2024 7:30am
